CRMD Price / Book | CORMEDIX INC.

CorMedix Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

CorMedix Inc. price/book ratio for the quarter ending 2026-06-30 was 1.32, a 68.26% decline year-over-year.
CorMedix Inc. price/book ratio for the quarter ending 2026-03-31 was 1.22, a 66.43% decline year-over-year.
CorMedix Inc. price/book ratio for the quarter ending 2025-12-31 was 2.27, a 63.13% decline year-over-year.
CorMedix Inc. price/book ratio for the quarter ending 2025-09-30 was 2.43, a 69.44% decline year-over-year.
CorMedix Inc. price/book ratio for fiscal 2026 was 1.32.
CorMedix Inc. price/book ratio for fiscal 2025 was 2.27, a 63.13% decline from fiscal 2024.
CorMedix Inc. price/book ratio for fiscal 2024 was 6.16, a 109.27% increase from fiscal 2023.
CorMedix Inc. price/book ratio for fiscal 2023 was 2.94, a 10.26% decline from fiscal 2022.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	1.32	$608.91M	$460.83M
2026-03-31	1.22	$532.7M	$437.05M
2025-12-31	2.27	$921.01M	$405.31M
2025-09-30	2.43	$910.81M	$374.13M
2025-06-30	4.16	$918.58M	$220.63M
2025-03-31	3.63	$417.1M	$114.89M
2024-12-31	6.16	$521.73M	$84.66M
2024-09-30	7.97	$467.73M	$58.71M
2024-06-30	5.18	$239.34M	$46.18M
2024-03-31	4.02	$233.03M	$58.01M
2023-12-31	2.94	$206.57M	$70.14M
2023-09-30	2.44	$202.8M	$83.2M
2023-06-30	3.71	$181.85M	$49.05M
2023-03-31	3.42	$184.23M	$53.93M
2022-12-31	3.28	$180.68M	$55.06M
2022-09-30	2.07	$116.62M	$56.31M
2022-06-30	2.68	$165.25M	$61.74M
2022-03-31	3.54	$212.23M	$59.87M
2021-12-31	2.76	$173.29M	$62.8M
2021-09-30	2.55	$177.1M	$69.34M
2021-06-30	3.4	$261.27M	$76.87M
2021-03-31	4.73	$380.08M	$80.32M
2020-12-31	5.64	$249.34M	$44.22M
2020-09-30	5.48	$189.03M	$34.47M
2020-06-30	8.89	$164.6M	$18.52M
2020-03-31	4.34	$93.8M	$21.59M
2019-12-31	7.9	$186.84M	$23.65M
2019-09-30	5.7	$163.65M	$28.71M
2019-06-30	12.97	$213.67M	$16.48M
2019-03-31	13.6	$225.02M	$16.54M
2018-12-31	28.46	$140.45M	$4.93M
2018-09-30	-50.47	$479.31M	-$9.5M
2018-06-30	-15.75	$102.02M	-$6.48M
2018-03-31	87.56	$73.61M	$840,692.00
2017-12-31	24.82	$178.53M	$7.19M
2017-09-30	16.65	$161.14M	$9.68M
2017-06-30	8.3	$127.58M	$15.37M
2017-03-31	30.05	$331.87M	$11.04M
2016-12-31	17.36	$309.31M	$17.81M
2016-09-30	21.41	$509.11M	$23.78M
2016-06-30	13.22	$371.1M	$28.07M
2016-03-31	15.69	$478.83M	$30.52M
2015-12-31	10.73	$365.03M	$34.01M
2015-09-30	9.67	$352M	$36.39M
2015-06-30	18.01	$663.71M	$36.85M
2015-03-31	180.48	$1.37B	$7.6M
2014-12-31	59.02	$214.51M	$3.63M
2014-09-30	37.63	$209.86M	$5.58M
2014-06-30	-124.35	$199.06M	-$1.6M
2014-03-31	-74.02	$276.02M	-$3.73M
2013-12-31	-25.6	$102.96M	-$4.02M
2013-09-30	-26.81	$73.41M	-$2.74M
2013-06-30	-31.57	$64.21M	-$2.03M
2013-03-31	-42.73	$48.12M	-$1.13M
2012-12-31	-122.46	$41.07M	-$335,376.00
2012-09-30	-33.57	$14.83M	-$441,822.00
2012-06-30	-83.49	$11.98M	-$143,483.00
2012-03-31	63.37	$26.81M	$423,029.00
2011-12-31	11.99	$15.97M	$1.33M
2011-09-30	70.35	$51.91M	$737,844.00
2011-06-30	25.57	$82.71M	$3.23M
2010-12-31	14.31	$103.82M	$7.26M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	1.32	$608.91M	$460.83M
2025-12-31	2.27	$921.01M	$405.31M
2024-12-31	6.16	$521.73M	$84.66M
2023-12-31	2.94	$206.57M	$70.14M
2022-12-31	3.28	$180.68M	$55.06M
2021-12-31	2.76	$173.29M	$62.8M
2020-12-31	5.64	$249.34M	$44.22M
2019-12-31	7.9	$186.84M	$23.65M
2018-12-31	28.46	$140.45M	$4.93M
2017-12-31	24.82	$178.53M	$7.19M
2016-12-31	17.36	$309.31M	$17.81M
2015-12-31	10.73	$365.03M	$34.01M
2014-12-31	59.02	$214.51M	$3.63M
2013-12-31	-25.6	$102.96M	-$4.02M
2012-12-31	-122.46	$41.07M	-$335,376.00
2011-12-31	11.99	$15.97M	$1.33M
2010-12-31	14.31	$103.82M	$7.26M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Aquestive Therapeutics, Inc. (AQST)	United States	$0.606B	-6.67
IMPACT BIOMEDICAL INC. (IBO)	United States	$0.611B	66.47
CytomX Therapeutics, Inc. (CTMX)	United States	$0.598B	-10.25
Monopar Therapeutics (MNPR)	United States	$0.598B	-34.82
Altimmune, Inc. (ALT)	United States	$0.593B	-6.43
Neurogene Inc. (NGNE)		$0.625B	-4.46
Shattuck Labs, Inc. (STTK)	United States	$0.634B	-13.30
Phathom Pharmaceuticals, Inc. (PHAT)	United States	$0.572B	-8.76
BlossomHill Therapeutics, Inc. (BLSM)	United States	$0.647B
ZEVRA THERAPEUTICS, INC. (ZVRA)	United States	$0.668B	14.61